Next-generation sequencing of a combinatorial peptide phage library screened against ubiquitin identifies peptide aptamers that can inhibit the

aptamers molecular dynamics next-generation sequencing phage-peptide protein–peptide binding ubiquitin

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 14 02 2022
accepted: 13 10 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 20 12 2022
Statut: epublish

Résumé

Defining dynamic protein-protein interactions in the ubiquitin conjugation reaction is a challenging research area. Generating peptide aptamers that target components such as ubiquitin itself, E1, E2, or E3 could provide tools to dissect novel features of the enzymatic cascade. Next-generation deep sequencing platforms were used to identify peptide sequences isolated from phage-peptide libraries screened against Ubiquitin and its ortholog NEDD8. In over three rounds of selection under differing wash criteria, over 13,000 peptides were acquired targeting ubiquitin, while over 10,000 peptides were selected against NEDD8. The overlap in peptides against these two proteins was less than 5% suggesting a high degree in specificity of Ubiquitin or NEDD8 toward linear peptide motifs. Two of these ubiquitin-binding peptides were identified that inhibit both E3 ubiquitin ligases MDM2 and CHIP. NMR analysis highlighted distinct modes of binding of the two different peptide aptamers. These data highlight the utility of using next-generation sequencing of combinatorial phage-peptide libraries to isolate peptide aptamers toward a protein target that can be used as a chemical tool in a complex multi-enzyme reaction.

Identifiants

pubmed: 36532480
doi: 10.3389/fmicb.2022.875556
pmc: PMC9755681
doi:

Types de publication

Journal Article

Langues

eng

Pagination

875556

Informations de copyright

Copyright © 2022 Lisowska, Lickiss, Gil-Mir, Huart, Trybala, Way, Hernychova, Krejci, Muller, Krejcir, Zhukow, Jurczak, Rodziewicz-Motowidło, Ball, Vojtesek, Hupp and Kalathiya.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell. 2002 Dec 27;111(7):1041-54
pubmed: 12507430
Cell Death Differ. 2017 May;24(5):903-916
pubmed: 28362432
Biochim Biophys Acta. 2014 Jan;1843(1):47-60
pubmed: 23747565
J Biol Chem. 2009 Apr 24;284(17):11517-30
pubmed: 19188367
Cell Commun Signal. 2015 Nov 18;13:42
pubmed: 26581338
Science. 2013 Feb 1;339(6119):590-5
pubmed: 23287719
J Chromatogr. 1983 Sep 23;268(1):112-9
pubmed: 6355135
J Am Chem Soc. 2002 Mar 6;124(9):1852-3
pubmed: 11866588
Mol Cell. 2009 Dec 25;36(6):1095-102
pubmed: 20064473
Cytokine. 2015 Dec;76(2):569-571
pubmed: 25805508
J Am Soc Mass Spectrom. 1998 Mar;9(3):225-33
pubmed: 9879360
Mol Cell. 2006 Jul 21;23(2):251-63
pubmed: 16857591
J Chromatogr. 1986 Dec 26;371:313-33
pubmed: 3494031
Mol Cell Proteomics. 2015 Nov;14(11):2973-87
pubmed: 26330542
Bioinformatics. 2015 Apr 15;31(8):1325-7
pubmed: 25505092
Proteomics. 2013 Aug;13(16):2512-25
pubmed: 23776060
Mol Cell. 2014 Jul 17;55(2):161-9
pubmed: 25038412
Science. 2007 May 25;316(5828):1160-6
pubmed: 17525332
EMBO J. 2013 Sep 11;32(18):2504-16
pubmed: 23942235
Chembiochem. 2022 Jan 19;23(2):e202100270
pubmed: 34494353
Science. 2004 Feb 6;303(5659):844-8
pubmed: 14704432
Biochemistry. 2007 Dec 4;46(48):13742-51
pubmed: 17994709
J Biomol NMR. 1995 Sep;6(2):153-62
pubmed: 8589604
Annu Rev Biochem. 2012;81:203-29
pubmed: 22524316
Biochim Biophys Acta. 2014 Jan;1843(1):61-74
pubmed: 23545411
Nat Rev Mol Cell Biol. 2015 May;16(5):322-4
pubmed: 25907614
Oncogene. 2016 Jan 28;35(4):415-26
pubmed: 25867069
EMBO Rep. 2012 Oct;13(10):877-9
pubmed: 22986552
J Am Chem Soc. 2013 Mar 20;135(11):4364-71
pubmed: 23437920
J Mol Biol. 2008 Jan 25;375(4):979-96
pubmed: 18054791
Annu Rev Biochem. 2015;84:435-64
pubmed: 25784053
Mol Cell Proteomics. 2018 Apr;17(4):737-763
pubmed: 29339412
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8073-8
pubmed: 22556265
Curr Biol. 2014 Mar 17;24(6):R215-20
pubmed: 24650902
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
PLoS One. 2015 Mar 13;10(3):e0120329
pubmed: 25768649
Mol Cell. 2011 Apr 8;42(1):75-83
pubmed: 21474069
J Biol Chem. 2002 Aug 9;277(32):28446-58
pubmed: 11925449
Oncogene. 1996 Nov 21;13(10):2141-7
pubmed: 8950981
J Am Soc Nephrol. 2010 Feb;21(2):316-26
pubmed: 19959714
J Mol Biol. 2015 Apr 24;427(8):1728-47
pubmed: 25543083
J Biol Chem. 2001 Aug 10;276(32):30483-9
pubmed: 11399765
Nat Rev Mol Cell Biol. 2009 Oct;10(10):659-71
pubmed: 19773779
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Science. 1985 Jun 14;228(4705):1315-7
pubmed: 4001944
Cell. 2011 Jun 24;145(7):1075-87
pubmed: 21683433
Nat Chem Biol. 2014 Feb;10(2):156-163
pubmed: 24316736
Biochemistry. 1994 May 17;33(19):5984-6003
pubmed: 7514039
Nucleic Acids Res. 2014 Jan;42(Database issue):D259-66
pubmed: 24214962
Molecules. 2011 Feb 21;16(2):1776-803
pubmed: 21339712
Angew Chem Int Ed Engl. 2010 Jul 19;49(31):5301-4
pubmed: 20583018
Methods Enzymol. 2014;545:243-63
pubmed: 25065893
Biochem J. 2011 Jan 1;433(1):31-42
pubmed: 21158740
J Biomol NMR. 1995 Sep;6(2):135-40
pubmed: 8589602
Methods. 2012 Sep;58(1):47-55
pubmed: 22819855
J Mol Biol. 2004 Mar 12;337(1):129-45
pubmed: 15001357
PLoS One. 2009 Dec 17;4(12):e8338
pubmed: 20020040
J Biol Chem. 2009 Jan 2;284(1):334-344
pubmed: 18974095

Auteurs

Małgorzata Lisowska (M)

International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.

Fiona Lickiss (F)

International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.

Maria Gil-Mir (M)

University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.

Anne-Sophie Huart (AS)

University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.

Zuzanna Trybala (Z)

International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.

Luke Way (L)

University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.

Lenka Hernychova (L)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Adam Krejci (A)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Petr Muller (P)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Radovan Krejcir (R)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Igor Zhukow (I)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.

Przemyslaw Jurczak (P)

Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland.

Sylwia Rodziewicz-Motowidło (S)

Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland.

Kathryn Ball (K)

University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.

Borivoj Vojtesek (B)

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.

Ted Hupp (T)

University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.

Umesh Kalathiya (U)

International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.

Classifications MeSH